PRURITUS RESOURCES
  • Home
  • 9. Pruritussymposium
    • Information
    • Anmeldung
    • Impressionen
  • Prurigo Nodularis League
  • Chronic Prurigo Guideline
  • Measuring Instruments
    • Itch Intensity >
      • Numerical Rating Scale
      • Visual Analogue Scale
      • Verbal Rating Scale
    • Quality of Life >
      • ItchyQoL
      • DLQI
    • Course of Itch >
      • ItchApp
      • ItchyApp
      • 5-D Itch Scale
      • Itch Controlled Days
      • Dynamic Pruritus Score
      • Patient Benefit Index- Pruritus
    • Deutscher Pruritusfragebogen
  • Task Force Pruritus
    • European Prurigo Project >
      • Pereira et al. J Eur Acad Dermatol Venerol 2022
      • Pereira et al. Acta Derm Venerol 2021
      • Reverte et. al. Ann dermatol Venereol 2020
      • Pereira et al. J Eur Dermatol Venereol 2020
      • Pereira et al. Acta Derm Venereol 2020
      • Pereira et al. ITch 2019
      • Pereira et al. Exp dermatol 2019
      • Pereira et al. curr opin pharmacol 2019
      • Verweyen et al. Acta Derm Venereol 2019
      • Pereira et al. j eur acad dermatol venereol 2019
      • Pereira et al. expert opin investig drugs 2018
      • Pölking et al. J eur acad dermatol venereol 2018
      • Pereira et al. Hautarzt 2018
      • Pereira et al. j eur acad dermatol venerol 2018
      • Pereira et al. j eur acad dermatol venereol 2018
      • Zeidler et al. acta derm venereol 2018
      • Pereira et al. acta derm venereol 2018
      • Pereira et al. itch 2017
      • Pereira et al. drugs 2017
    • Definition of Severity and Descriptors of Chronic Prurigo – Harmonization of European Prurigo Documentation
  • Contact
  • Disclaimer
  • Home
  • 9. Pruritussymposium
    • Information
    • Anmeldung
    • Impressionen
  • Prurigo Nodularis League
  • Chronic Prurigo Guideline
  • Measuring Instruments
    • Itch Intensity >
      • Numerical Rating Scale
      • Visual Analogue Scale
      • Verbal Rating Scale
    • Quality of Life >
      • ItchyQoL
      • DLQI
    • Course of Itch >
      • ItchApp
      • ItchyApp
      • 5-D Itch Scale
      • Itch Controlled Days
      • Dynamic Pruritus Score
      • Patient Benefit Index- Pruritus
    • Deutscher Pruritusfragebogen
  • Task Force Pruritus
    • European Prurigo Project >
      • Pereira et al. J Eur Acad Dermatol Venerol 2022
      • Pereira et al. Acta Derm Venerol 2021
      • Reverte et. al. Ann dermatol Venereol 2020
      • Pereira et al. J Eur Dermatol Venereol 2020
      • Pereira et al. Acta Derm Venereol 2020
      • Pereira et al. ITch 2019
      • Pereira et al. Exp dermatol 2019
      • Pereira et al. curr opin pharmacol 2019
      • Verweyen et al. Acta Derm Venereol 2019
      • Pereira et al. j eur acad dermatol venereol 2019
      • Pereira et al. expert opin investig drugs 2018
      • Pölking et al. J eur acad dermatol venereol 2018
      • Pereira et al. Hautarzt 2018
      • Pereira et al. j eur acad dermatol venerol 2018
      • Pereira et al. j eur acad dermatol venereol 2018
      • Zeidler et al. acta derm venereol 2018
      • Pereira et al. acta derm venereol 2018
      • Pereira et al. itch 2017
      • Pereira et al. drugs 2017
    • Definition of Severity and Descriptors of Chronic Prurigo – Harmonization of European Prurigo Documentation
  • Contact
  • Disclaimer
PRURITUS RESOURCES
Patient Benefit Index- Pruritus (PBI-P)

The PBI-P is a questionnaire with 27 items comprised of two parts:

  1. A patient needs questionnaire (distributed pre-therapy)
  2. A patient benefits questionnaire (distributed post-therapy)

It was developed in order to evaluate the care situation of affected patients via an analysis of their therapeutic needs and treatment goals. The PBI-P allows for the identification of the importance of goals related not only to a variety of clinical symptoms, but also to psychological and social dimensions.

  • Time needed for completion: 10-15 minutes
  • Languages: Polish, German and English

References:
  • Steinke S, Bruland P, Blome C, Osada N, Dugas M, Fritz F, Augustin M, Ständer S. Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex. Br J Dermatol. 2017 Feb;176(2):363-370.
  • Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Blome C, Augustin M, Siepmann D, Phan NQ, Rustenbach SJ, Ständer S. Br J Dermatol. 2009 Nov;161(5):1143-8. doi: 10.1111/j.1365-2133.2009.09328.x.